German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a ...
Bayer AG said an experimental stroke-prevention drug showed positive results in a late-stage clinical study, a boost for the ...
The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...
FDA grants accelerated approval to Bayer's Hyrnuo and full approval to Amgen's Imdelltra, expanding treatment options for ...
The accelerated FDA approval of Bayer's Hyrnuo covers treatment of advanced cases of non-small cell lung cancer with HER2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback